Citius Pharmaceuticals, Inc.

Quotes on small-cap drugmaker Citius Pharmaceuticals <a href="https://finance.yahoo.com/quote/CTXR/">plummeted</a> almost 20% to a record low yesterday, April 1, after the company <a href="https://citiuspharma.com/investors/news-media/news/release-details/2025/Citius-Pharmaceuticals-Announces-2-Million-Registered-Direct-Offering-of-Common-Stock/default.aspx">announced</a> a direct offering at a steep discount to the current share price.

Drugmaker Citius Pharma sells off after new direct offering announced


SatixFy, an Israel-based but U.S.-listed small company that specializes in vertically integrated satellite communication systems and ground terminal chips, is being acquired at a significant premium by its long-time partner, Canada’s MDA Space, whose technology is used by Eutelsat. SatixFy shares <a href="https://finance.yahoo.com/quote/SATX/">skyrocketed</a> 64% on the news yesterday.

Satcom small cap SatixFy soars 64% on news of being acquired by MDA Space


Sidus Space, Inc.

Shares of micro-cap space services provider Sidus Space have <a href="https://www.marketwatch.com/investing/stock/sidu?mod=search_symbol">slid</a> more than 6% in premarket trading today, April 1, after the company <a href="https://investors.sidusspace.com/news-events/press-releases/detail/229/sidus-space-reports-full-year-2024-financial-results-and">released</a> its 2024 financial results, which showed a deterioration in nearly all key metrics.

Sidus Space tumbles on disappointing 2024 financials


Viomi Technology Co., Ltd

Zacks Small-Cap Research (Zacks SCR) has <a href="https://scr.zacks.com/news/news-details/2025/VIOT-A-deep-value-growth-story-delivers-solid-results--Increasing-our-estimates-and-valuation-target-to-4-50-article/default.aspx">raised</a> its target price for Viomi Technology by 20%. The Chinese manufacturer of AI-powered water purification systems, whose ADRs trade on the Nasdaq, is in the midst of a restructuring that appears to be yielding results.&nbsp;&nbsp;

Zacks raises target price by 20% for Chinese AI water purifier maker Viomi  


The Goodyear Tire & Rubber Company

Deutsche Bank upgraded Goodyear Tire &amp; Rubber Co. from “hold” to “buy” yesterday, March 31, as it believes the U.S. small-cap tire manufacturer stands to gain from President Donald Trump’s tariffs on car imports.

Deutsche Bank spotlights Goodyear as a winner from U.S. auto tariffs


JinkoSolar Holding Co., Ltd.

Freedom Holdings Corp.

Freedom Broker has revised downward its recommendation and target price on JinkoSolar Holding, a Chinese small-cap solar panel manufacturer listed in New York. It now rates the stock a “sell,” even after it slashed its target price by more than half, citing as reasons narrowing margins, a <a href="https://ir.jinkosolar.com/news-releases/news-release-details/jinkosolar-announces-fourth-quarter-and-full-year-2024-financial">net loss</a> in the fourth quarter, and a bleak management outlook for 2025.&nbsp;&nbsp;

Freedom Holding broker delivers big downgrade to small cap JinkoSolar  

Wolfspeed, Inc.

Quotes on small-cap semiconductor manufacturer Wolfspeed <a href="https://www.marketwatch.com/investing/stock/wolf">plummeted</a> almost 52% on Friday, March 28, hitting their <a href="https://finance.yahoo.com/chart/WOLF#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">lowest</a> level in nearly three decades. Reuters <a href="https://www.reuters.com/technology/chipmaker-wolfspeeds-shares-plunge-over-45-27-year-low-2025-03-28/">attributes</a> the decline to uncertainty over federal funding.

Chipmaker Wolfspeed loses half of market value amid federal funding uncertainty


Last week, investors rotated capital into large caps and stocks of companies with higher debt levels. In a continuation of the year-to-date trend, the Russell 2000 underperformed the S&amp;P 500, which signals growing market concerns about a potential recession.&nbsp;&nbsp;

Key trends in small caps: Recession and tariff fears, reallocation to bigger stocks  

Equillium, Inc.

Shares of Equillium, a biotech company with a market capitalization of $17.3 million, <a href="https://www.marketwatch.com/investing/stock/eq">plummeted</a> over 36% yesterday, March 27, hitting their lowest level in about a year and a half. The <a href="https://www.equilliumbio.com/investors/press-releases/news-details/2025/Equillium-Announces-Results-of-the-Phase-3-EQUATOR-Study-of-Itolizumab-in-First-Line-Treatment-of-Patients-with-Acute-Graft-Versus-Host-Disease/default.aspx">trigger</a> was clinical trial results for its transplant rejection drug that showed no advantage over placebo in the first month of treatment but more promising long-term performance.&nbsp;&nbsp;

Mixed trial results for transplant rejection drug send Equillium plunging 36%


Soleno Therapeutics, Inc.

Shares of biotech small cap Soleno Therapeutics jumped almost 38% yesterday, March 27, after the U.S. FDA <a href="https://investors.soleno.life/news-releases/news-release-details/soleno-therapeutics-announces-us-fda-approval-vykattm-xr-treat">approved</a> its drug for a genetic disorder that causes insatiable hunger. It is the first approved medication designed for this.

Biotech small cap Soleno gets FDA approval for hunger treatment, shares soar


Usio, Inc.

Shares of fintech small cap Usio have <a href="https://www.marketwatch.com/investing/stock/usio?mod=search_symbol">jumped</a> nearly 7% in premarket trading today, March 27, after the company <a href="https://usio.com/usio-press-and-news/?utm_campaign=Investor%20Relations&amp;utm_medium=email&amp;_hsenc=p2ANqtz-_AeHlNCEjq1mIs8LKZiFm2W64vw9C7SEceeAugZRbMXvSE1lRzJPF98w1jXnw7gCy1vnZpzPrzLQ9X9nMttB9vw6pkfSsc5yI2xWeEBljnw09LsAg&amp;_hsmi=353733761&amp;utm_content=353733761&amp;utm_source=hs_email">reported</a> improved profitability and cash flow in 2024. This will allow Usio to <a href="https://usio.com/usio-press-and-news/?utm_campaign=Investor%20Relations&amp;utm_medium=email&amp;_hsenc=p2ANqtz-_AeHlNCEjq1mIs8LKZiFm2W64vw9C7SEceeAugZRbMXvSE1lRzJPF98w1jXnw7gCy1vnZpzPrzLQ9X9nMttB9vw6pkfSsc5yI2xWeEBljnw09LsAg&amp;_hsmi=353733761&amp;utm_content=353733761&amp;utm_source=hs_email">expand</a> and extend for another three years its stock buyback program.&nbsp;&nbsp;

Fintech Usio climbs after positive earnings, buyback expansion 


VolitionRx Limited

Quotes on VolitionRx, a small-cap company developing a cancer test that requires only a drop of blood and could become as routine as a pregnancy test, <a href="https://www.marketwatch.com/investing/stock/vnrx">slid</a> almost 7% yesterday, March 26, closing at its lowest level since mid-August. The trigger was the company's <a href="https://ir.volition.com/news-events/press-releases/detail/836/volitionrx-announces-pricing-of-up-to-2-3-million-registered-direct-offering">announcement</a> of a $2.3 million direct offering.

Small caps